Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Hematology

Why Does PNH Cause Severe Fatigue? Key Causes Explained

At a Glance

PNH can cause disabling fatigue even when hemoglobin is stable. Ongoing red blood cell destruction, iron lost in urine, inflammation, kidney strain, and bone marrow failure can all reduce energy, so LDH and other hemolysis tests help explain the full picture.

In Paroxysmal Nocturnal Hemoglobinuria (PNH), fatigue can be severe and is notoriously out of proportion to your degree of anemia [1]. While typical anemia causes tiredness because a lack of red blood cells deprives your tissues of oxygen, PNH fatigue is multifactorial. It is often heavily influenced by intravascular hemolysis—the continuous or intermittent destruction of red blood cells within your blood vessels [2].

This process releases cellular contents that can deplete essential molecules [3], cause urinary iron loss [4], and contribute to a chronic inflammatory state [5]. Because your body is managing this ongoing systemic stress, your exhaustion can be debilitating even if your hemoglobin numbers appear relatively stable [6].

⚠️ IMPORTANT SAFETY WARNING
Abdominal pain or rapidly worsening fatigue in PNH should never be dismissed. Abdominal pain can be a sign of thrombosis (a blood clot in an abdominal vein), which is a life-threatening medical emergency. Seek urgent medical evaluation for sudden or severe abdominal pain, chest pain, shortness of breath, one-sided leg swelling, severe headache, confusion, weakness, or a major change in your urine output.

The “Nitric Oxide Sponge” and Muscle Spasms

When red blood cells break apart in the bloodstream, they release free hemoglobin [2]. This cell-free hemoglobin acts like a sponge, soaking up and depleting a crucial molecule in your blood called nitric oxide (NO) [3]. Nitric oxide is essential for keeping your blood vessels relaxed and your smooth muscles functioning properly [7].

When NO is depleted, one proposed result is that your body may experience smooth muscle spasms or tightening [7]. These spasms can contribute to sudden abdominal pain, difficulty swallowing (dysphagia), and erectile dysfunction [8]. Operating with constricted blood vessels and spasming muscles requires extra energy and can add a heavy burden of physical fatigue [2].

Chronic Iron Loss Through Urine

In PNH, some of the contents from destroyed red blood cells are filtered by your kidneys and lost in your urine—a process called hemoglobinuria and hemosiderinuria [4]. This can lead to an ongoing loss of iron [9].

Because of this urinary drain, iron deficiency is common. One survey found it affected approximately 76% of patients with classical PNH [9]. Since iron is a fundamental building block for cellular energy, lacking it can cause profound fatigue [10].

Note: Never start high-dose iron supplements on your own. Iron replacement in PNH must be carefully guided and monitored by your hematologist, as rapidly increasing red blood cell production can sometimes trigger more hemolysis [10].

Inflammation and Organ Strain

The destruction of cells and the ongoing activity of the complement system (a part of your immune system) can keep your body in a state of chronic inflammation [5]. Inflammatory signals circulating in your blood can make you feel deeply exhausted, similar to the body aches and exhaustion you feel when fighting off a virus [5].

Additionally, filtering out free hemoglobin and iron can cause oxidative stress in the kidneys [3]. Over time, this may contribute to kidney injury and dysfunction [11]. Dealing with chronic inflammation and impaired organ function takes a significant toll on your daily stamina. Furthermore, PNH often coexists with underlying bone marrow failure, adding another layer of physical exhaustion that cannot be explained by hemolysis alone [12].

Why Hemoglobin Isn’t the Only Number That Matters

In standard anemia, doctors look primarily at hemoglobin to measure disease severity. However, studies show that in PNH, fatigue can sometimes correlate strongly with LDH (lactate dehydrogenase) levels [6]. LDH is an enzyme used as a marker to estimate how much active cell destruction is occurring [6].

Even if your body produces enough new red blood cells to keep your hemoglobin stable, a high rate of ongoing cell destruction (reflected by high LDH) can drive systemic fatigue [13]. Clinicians interpret LDH alongside other tests—such as reticulocytes, bilirubin, and haptoglobin—to get a full picture of your hemolysis [14].

This explains why treatments like complement inhibitors, which reduce hemolysis, can sometimes improve energy levels even if hemoglobin only rises slightly [6] [15]. However, it is important to know that these treatments do not perfectly stop all cell destruction. You may still experience fatigue due to:

  • Breakthrough hemolysis: Episodes where intravascular hemolysis temporarily flares up despite treatment [16].
  • Residual extravascular hemolysis: When red blood cells are tagged by the immune system and destroyed outside the blood vessels (often in the spleen or liver), leaving you with ongoing anemia [17].

If your fatigue worsens or persists, it deserves a broader clinical evaluation. Your care team should investigate whether it is caused by residual hemolysis, iron deficiency, kidney issues, or entirely different factors like sleep disturbances, medications, or thyroid problems.

Common questions in this guide

Why can fatigue from PNH be severe even when my hemoglobin is stable?
Paroxysmal nocturnal hemoglobinuria can cause ongoing red blood cell destruction that is not fully reflected by the hemoglobin number. Free hemoglobin, iron loss in the urine, chronic inflammation, kidney strain, and underlying bone marrow failure can all reduce energy. This is why fatigue may remain severe even when anemia appears stable.
What does a high LDH level mean when I have PNH fatigue?
LDH is a blood-test marker that can rise when red blood cells are being destroyed. In PNH, a high LDH level may help show active hemolysis and can correlate with fatigue, even if hemoglobin has not changed much. Clinicians interpret LDH with reticulocytes, bilirubin, haptoglobin, and your symptoms.
Could iron deficiency be causing my PNH exhaustion?
Yes. PNH can cause ongoing iron loss when hemoglobin from destroyed red blood cells passes through the kidneys and leaves in the urine. Iron deficiency can worsen fatigue, but iron supplements should be started and monitored by a hematologist because treatment can sometimes increase red blood cell production and trigger more hemolysis.
Can complement inhibitor treatment improve fatigue in PNH?
Complement inhibitors reduce the red blood cell destruction that drives many PNH symptoms, so they may improve energy even if hemoglobin rises only slightly. Fatigue can persist if breakthrough hemolysis or destruction outside blood vessels remains, or if iron deficiency, kidney problems, or another condition is contributing.
When should worsening PNH fatigue or abdominal pain be treated as an emergency?
Sudden or severe abdominal pain, rapidly worsening fatigue, chest pain, shortness of breath, one-sided leg swelling, severe headache, confusion, weakness, or a major change in urine output needs urgent medical evaluation. These symptoms can signal a blood clot or other serious complication, and abdominal vein thrombosis can be life-threatening.
What other causes of fatigue should be checked in someone with PNH?
A care team may assess for residual hemolysis, iron deficiency, kidney involvement, and bone marrow failure. Sleep disturbances, medication effects, thyroid problems, and other health conditions can also cause fatigue, so persistent or worsening symptoms deserve a broader evaluation.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Paroxysmal nocturnal hemoglobinuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my LDH, reticulocytes, and bilirubin, how well-controlled is my hemolysis right now?
  2. 2.Could my current fatigue be related to iron deficiency, and should we evaluate my iron stores?
  3. 3.Are there signs of kidney strain or other organ involvement that might be contributing to my exhaustion?
  4. 4.If I am on a complement inhibitor, is it possible I am experiencing breakthrough hemolysis or residual extravascular hemolysis?
  5. 5.Should we evaluate other potential causes for my fatigue, such as bone marrow failure, thyroid issues, or sleep disturbances?

References

References (17)
  1. 1

    Even mild hemolysis in paroxysmal nocturnal hemoglobinuria could severely compromise the quality of life due to long-term sustained intolerant fatigue.

    Sakai K

    Leukemia research reports 2020; (14()):100224 doi:10.1016/j.lrr.2020.100224.

    PMID: 33083224
  2. 2

    A Rare Case of Paroxysmal Nocturnal Hemoglobinuria With Bilateral Renal Vein Thrombosis.

    Lodhi OUH, Sohail S, Hassan D

    Cureus 2020; (12(6)):e8806 doi:10.7759/cureus.8806.

    PMID: 32724752
  3. 3

    Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment.

    Kokoris SI, Gavriilaki E, Miari A, et al.

    Hematology (Amsterdam, Netherlands) 2018; (23(8)):558-566 doi:10.1080/10245332.2018.1444563.

    PMID: 29486674
  4. 4

    Iron Deficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Cross-Sectional Survey from a Single Institution in China.

    Peng G, Yang W, Jing L, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2018; (24()):7256-7263 doi:10.12659/MSM.910614.

    PMID: 30306969
  5. 5

    Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.

    Kokoris S, Polyviou A, Evangelidis P, et al.

    International journal of molecular sciences 2024; (25(22)) doi:10.3390/ijms252212104.

    PMID: 39596172
  6. 6

    Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.

    Schrezenmeier H, Kulasekararaj A, Mitchell L, et al.

    Annals of hematology 2024; (103(1)):5-15 doi:10.1007/s00277-023-05483-0.

    PMID: 37804344
  7. 7

    Ten Years of Clinical Experience With Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria.

    Sicre de Fontbrune F, Peffault de Latour R

    Seminars in hematology 2018; (55(3)):124-129 doi:10.1053/j.seminhematol.2018.04.001.

    PMID: 30032748
  8. 8

    Analysis of clinical characteristics of 92 patients with paroxysmal nocturnal hemoglobinuria: A single institution experience in China.

    Fu R, Li L, Li L, et al.

    Journal of clinical laboratory analysis 2020; (34(1)):e23008 doi:10.1002/jcla.23008.

    PMID: 31502726
  9. 9

    Hemolytic anemia, iron deficiency and personal history of deep vein thrombosis: consider paroxysmal nocturnal hemoglobinuria.

    Gendron N, Arlet JB, Gaussem P, et al.

    Annales de biologie clinique 2017; (75(5)):580-588 doi:10.1684/abc.2017.1277.

    PMID: 28958970
  10. 10

    [Evaluation of the efficacy and safety of iron therapy in patients with paroxysmal nocturnal hemoglobinuria complicated with iron deficiency anemia].

    Peng GX, Zhang L, Yang WR, et al.

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2020; (41(8)):671-674 doi:10.3760/cma.j.issn.0253-2727.2020.08.010.

    PMID: 32942822
  11. 11

    Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations.

    Oliver M, Patriquin CJ

    Journal of blood medicine 2023; (14()):613-628 doi:10.2147/JBM.S431493.

    PMID: 38084255
  12. 12

    [Advances in complement inhibition therapy for paroxysmal nocturnal hemoglobinuria].

    Shi YM, Zhang FK

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2025; (46(1)):90-96 doi:10.3760/cma.j.cn121090-20240903-00332.

    PMID: 40059689
  13. 13

    Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan.

    Ueda Y, Obara N, Yonemura Y, et al.

    International journal of hematology 2018; (107(6)):656-665 doi:10.1007/s12185-018-2409-3.

    PMID: 29383624
  14. 14

    Expert Consensus on the Diagnosis and Monitoring of Paroxysmal Nocturnal Hemoglobinuria (PNH): An Algorithmic Approach in an Era of New Treatments.

    Fattizzo B, Marchetti M, Cannizzo E, et al.

    European journal of haematology 2026; doi:10.1111/ejh.70294.

    PMID: 42675626
  15. 15

    Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria.

    Hillmen P, Szer J, Weitz I, et al.

    The New England journal of medicine 2021; (384(11)):1028-1037 doi:10.1056/NEJMoa2029073.

    PMID: 33730455
  16. 16

    Expert consensus on the management of pharmacodynamic breakthrough-hemolysis in treated paroxysmal nocturnal hemoglobinuria.

    Dingli D, De Castro Iii C, Koprivnikar J, et al.

    Hematology (Amsterdam, Netherlands) 2024; (29(1)):2329030 doi:10.1080/16078454.2024.2329030.

    PMID: 39665683
  17. 17

    Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.

    Risitano AM, Marotta S, Ricci P, et al.

    Frontiers in immunology 2019; (10()):1157 doi:10.3389/fimmu.2019.01157.

    PMID: 31258525

This page explains possible causes of severe fatigue in PNH for informational purposes only and does not constitute medical advice. Ask your hematologist about your symptoms, test results, and urgent warning signs.